• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Cracking The Code: Understanding Analyst Reviews For Doximity

    7/18/24 9:00:54 AM ET
    $DOCS
    EDP Services
    Technology
    Get the next $DOCS alert in real time by email

    4 analysts have expressed a variety of opinions on Doximity (NYSE:DOCS) over the past quarter, offering a diverse set of opinions from bullish to bearish.

    In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.

    Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
    Total Ratings 0 0 2 2 0
    Last 30D 0 0 0 1 0
    1M Ago 0 0 0 0 0
    2M Ago 0 0 0 0 0
    3M Ago 0 0 2 1 0

    The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $24.5, a high estimate of $29.00, and a low estimate of $19.00. Observing a downward trend, the current average is 8.14% lower than the prior average price target of $26.67.

    price target chart

    Decoding Analyst Ratings: A Detailed Look

    In examining recent analyst actions, we gain insights into how financial experts perceive Doximity. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

    Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
    Stan Berenshteyn Wells Fargo Lowers Underweight $19.00 $27.00
    Elizabeth Anderson Evercore ISI Group Raises In-Line $29.00 $28.00
    Anne Samuel JP Morgan Announces Neutral $25.00 -
    Ricky Goldwasser Morgan Stanley Maintains Underweight $25.00 $25.00

    Key Insights:

    • Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Doximity. This insight gives a snapshot of analysts' perspectives on the current state of the company.
    • Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Doximity compared to the broader market.
    • Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Doximity's stock. This comparison reveals trends in analysts' expectations over time.

    To gain a panoramic view of Doximity's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.

    Stay up to date on Doximity analyst ratings.

    Get to Know Doximity Better

    Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.

    Doximity: A Financial Overview

    Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.

    Revenue Growth: Doximity's remarkable performance in 3 months is evident. As of 31 March, 2024, the company achieved an impressive revenue growth rate of 6.39%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.

    Net Margin: Doximity's net margin excels beyond industry benchmarks, reaching 34.41%. This signifies efficient cost management and strong financial health.

    Return on Equity (ROE): Doximity's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 4.6%, the company showcases efficient use of equity capital and strong financial health.

    Return on Assets (ROA): Doximity's ROA excels beyond industry benchmarks, reaching 3.91%. This signifies efficient management of assets and strong financial health.

    Debt Management: Doximity's debt-to-equity ratio is below the industry average at 0.02, reflecting a lower dependency on debt financing and a more conservative financial approach.

    The Significance of Analyst Ratings Explained

    Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.

    Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $DOCS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DOCS

    DatePrice TargetRatingAnalyst
    2/6/2026$40.00Underweight → Neutral
    Analyst
    1/20/2026$55.00Equal Weight → Overweight
    Wells Fargo
    1/9/2026$59.00Outperform
    RBC Capital Mkts
    1/8/2026Hold → Buy
    Truist
    12/15/2025$65.00Equal-Weight → Overweight
    Morgan Stanley
    12/9/2025$63.00Overweight
    Barclays
    11/21/2025$65.00Outperform → Strong Buy
    Raymond James
    11/13/2025$55.00Market Perform
    BMO Capital Markets
    More analyst ratings

    $DOCS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Doximity Ranked #1 Best in KLAS Telehealth Video Platform for Fifth Consecutive Year

    Doximity Dialer earns A-level ratings in all categories Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, announced today that Doximity Dialer has been named the #1 Telehealth Video Conferencing Platform in the 2026 Best in KLAS Report. This is the fifth consecutive year that Doximity has earned the top spot, underscoring its position as a trusted, long-term partner for physicians and health systems. In addition to securing the #1 spot, Doximity received A-level ratings in all categories, including A+ ratings for culture, loyalty and value. These results are based on live interviews with health system leaders and their staff, reflecting high satisf

    2/5/26 4:05:00 PM ET
    $DOCS
    EDP Services
    Technology

    Doximity to Release Fiscal 2026 Third Quarter Results on February 5, 2026

    Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal third quarter ended December 31, 2025 after market close on February 5, 2026. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members inclu

    1/15/26 4:01:00 PM ET
    $DOCS
    EDP Services
    Technology

    Healthcare AI Exits Pilot Phase, Enters Production Deployment

    VANCOUVER, British Columbia, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary – Healthcare organizations are setting the pace for enterprise AI adoption as operational automation moves from experimentation to production scale across hospital systems[1]. The shift reflects a fundamental change in how healthcare leaders view AI technology, with deployment projected to expand the global healthcare AI market from $17.2 billion in 2025 to $77.2 billion by 2035[2]. Five publicly traded companies are positioned at the intersection of this operational transformation, delivering infrastructure that turns AI capabilities into measurable workflow improvements and financial returns

    12/12/25 9:59:27 AM ET
    $CERT
    $CTSH
    $DOCS
    Computer Software: Prepackaged Software
    Technology
    EDP Services
    Medical Specialities

    $DOCS
    SEC Filings

    View All

    SEC Form 10-Q filed by Doximity Inc.

    10-Q - Doximity, Inc. (0001516513) (Filer)

    2/5/26 4:09:11 PM ET
    $DOCS
    EDP Services
    Technology

    Doximity Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits

    8-K - Doximity, Inc. (0001516513) (Filer)

    2/5/26 4:03:25 PM ET
    $DOCS
    EDP Services
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Doximity Inc.

    SCHEDULE 13G/A - Doximity, Inc. (0001516513) (Subject)

    2/5/26 1:23:13 PM ET
    $DOCS
    EDP Services
    Technology

    $DOCS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Wampler Kira Scherer converted options into 2,000 shares and sold $74,660 worth of shares (2,000 units at $37.33) (SEC Form 4)

    4 - Doximity, Inc. (0001516513) (Issuer)

    2/4/26 4:11:16 PM ET
    $DOCS
    EDP Services
    Technology

    Director Wampler Kira Scherer converted options into 2,000 shares and sold $89,300 worth of shares (2,000 units at $44.65) (SEC Form 4)

    4 - Doximity, Inc. (0001516513) (Issuer)

    1/6/26 4:01:50 PM ET
    $DOCS
    EDP Services
    Technology

    Director Wampler Kira Scherer converted options into 2,000 shares and sold $101,420 worth of shares (2,000 units at $50.71) (SEC Form 4)

    4 - Doximity, Inc. (0001516513) (Issuer)

    12/3/25 4:03:07 PM ET
    $DOCS
    EDP Services
    Technology

    $DOCS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Doximity upgraded by Analyst with a new price target

    Analyst upgraded Doximity from Underweight to Neutral and set a new price target of $40.00

    2/6/26 8:05:27 AM ET
    $DOCS
    EDP Services
    Technology

    Doximity upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Doximity from Equal Weight to Overweight and set a new price target of $55.00

    1/20/26 8:43:16 AM ET
    $DOCS
    EDP Services
    Technology

    RBC Capital Mkts initiated coverage on Doximity with a new price target

    RBC Capital Mkts initiated coverage of Doximity with a rating of Outperform and set a new price target of $59.00

    1/9/26 9:04:54 AM ET
    $DOCS
    EDP Services
    Technology

    $DOCS
    Leadership Updates

    Live Leadership Updates

    View All

    Parspec Raises $20 Million Series A to Modernize the Construction Supply Chain with AI

    SAN MATEO, Calif., July 8, 2025 /PRNewswire/ -- Parspec, an AI-native software platform that enables wholesale distributors and sales agents to efficiently bid and supply construction products, today announced it has raised $20 million in Series A funding. The round was led by Threshold Ventures (formerly DFJ), with participation from existing venture investors including Innovation Endeavors, Building Ventures, Heartland Ventures, and Hometeam Ventures. Parspec Raises $20 Million Series A to Modernize the Construction Supply Chain with AIThe global construction industry repres

    7/8/25 9:30:00 AM ET
    $BOX
    $DOCS
    $RELY
    Computer Software: Prepackaged Software
    Technology
    EDP Services
    Real Estate

    Mendaera Closes $73M Series B Financing to Scale Robotics and AI Across Mainstream Medical Procedures

    With its first-of-its-kind platform, Mendaera is pioneering a new category in medical robotics Mendaera, Inc., a Silicon Valley-based healthcare technology company developing a handheld robotic interventional platform, announced today the close of $73 million in Series B funding led by Threshold Ventures, with participation from investors including Lux Capital, PFM Health Sciences, and Fred Moll (founder of Intuitive Surgical and Auris Health). The financing will further Mendaera's efforts to scale robotics and AI across mainstream medical procedures. The healthcare system is facing an increasing supply and demand crisis, where the ability to consistently deliver high-quality care to pati

    9/26/24 6:05:00 AM ET
    $DOCS
    $RELY
    $LVGO
    EDP Services
    Technology
    Real Estate
    Computer Software: Programming, Data Processing

    Doximity Appoints Phoebe Yang to Its Board of Directors

    Experienced director and executive brings health system and cloud expertise SAN FRANCISCO, Aug. 4, 2022 /PRNewswire/ -- Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced the appointment of Phoebe L. Yang to its Board of Directors. Ms. Yang has been General Manager at Amazon Web Services, Healthcare, and a member of the board of directors for CommonSpirit Health, one of the largest U.S. health systems. Ms. Yang is a long-time member of the Council on Foreign Relations, and has served as an appointee in two Presidential Administrations. In 2021, she was named one of Modern Healthcare's Top 100 Most Influential People in Healthcare and one

    8/4/22 4:02:00 PM ET
    $DOCS
    EDP Services
    Technology

    $DOCS
    Financials

    Live finance-specific insights

    View All

    Doximity to Release Fiscal 2026 Third Quarter Results on February 5, 2026

    Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal third quarter ended December 31, 2025 after market close on February 5, 2026. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members inclu

    1/15/26 4:01:00 PM ET
    $DOCS
    EDP Services
    Technology

    Doximity to Release Fiscal 2026 Second Quarter Results on November 6, 2025

    Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal second quarter ended September 30, 2025 after market close on November 6, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members inc

    10/16/25 4:01:00 PM ET
    $DOCS
    EDP Services
    Technology

    Doximity Acquires Pathway, a Leader in AI Clinical Reference

    $63M acquisition brings physician AI team and datasets to Doximity's AI suite Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced that it has acquired Pathway Medical Inc., a Montreal-based startup specializing in medical AI and evidence-based clinical reference. Physicians make up half of Pathway's team. Over the past seven years, they've assembled one of the largest structured datasets in medicine—purpose-built for AI—spanning nearly every guideline, drug, and landmark trial across all major specialties. Pathway's model outperforms others in clinical accuracy, recently scoring a record 96% on the U.S. Medical Licensing Examination (

    8/7/25 4:02:00 PM ET
    $DOCS
    EDP Services
    Technology

    $DOCS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Doximity Inc.

    SC 13G/A - Doximity, Inc. (0001516513) (Subject)

    11/14/24 5:22:01 PM ET
    $DOCS
    EDP Services
    Technology

    SEC Form SC 13G filed by Doximity Inc.

    SC 13G - Doximity, Inc. (0001516513) (Subject)

    11/14/24 11:42:53 AM ET
    $DOCS
    EDP Services
    Technology

    SEC Form SC 13G filed by Doximity Inc.

    SC 13G - Doximity, Inc. (0001516513) (Subject)

    11/12/24 9:55:17 AM ET
    $DOCS
    EDP Services
    Technology